Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-08-31
1993-07-13
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 47, A61K 3170
Patent
active
052273717
ABSTRACT:
Administration of adenine nucleotides to a host is followed by their rapid degradation to adenosine and inorganic phosphate which promote increases in liver ATP pools. The turnover of expanded liver ATP pools supply the adenosine precursor for the subsequent expansions of red blood cell (total blood) and blood plasma (extracellular) ATP pools. Thus, the administration of AMP, ATP or their degradation products adenosine and inorganic phosphate to a host, achieve the beneficial increases in liver, total blood and blood plasma ATP levels.
REFERENCES:
patent: 4141972 (1979-02-01), Nishino et al.
patent: 4880918 (1989-11-01), Rapaport
patent: 4923851 (1990-05-01), Carniglia
patent: 5030623 (1991-07-01), Gruber
"Principles of Biochemistry," Lehninger, The Johns Hopkins University School of Medicine, 1982.
"Biochemistry: The Chemical Reactions of Living Cells," Metzler, 1977.
"Adenosine Metabolism in Human Erythrocytes," Biochimica Et BioPhysica Acta, Meyskens, et al., 1971.
"How Cells Make ATP," Scientific American, Mar. 1978, Hinkle, et al.
Circulation Research, "A Dual Function for Adenosine 5'-Triphosphate in the Regulation of Vascular Tone," vol. 58, No. 3, Mar. 1986, Burnstock, et al.
European Journal of Pharmacology, "Evidence for Two Types of P.sub.2 -Purinoceptor in Longitudinal Muscle of the Rabbit Portal Vein," 111 (1985) 49-56, Burnstock et al.
Burnstock, "Purinergic Nerves," Pharmacological Reviews, vol. 24, No. 3.
"The Role of Adenosine in the Regulation of Coronary Blood Flow," Circulation Review, Dec. 1980, vol. 47, No. 6, Berne.
"ATP As a Co-Transmitter in Rat Tail Artery," European Journal of Pharmacology, 106 (1985) 149-152, Sneddon, et al.
"Platelet Metabolism and Activation," Seminars in Hematology, vol. 22, No. 3, Jul. 1985, pp. 219-240, Holmsen.
"Adenosine 5'-Triphosphate-(ATP) Mediated Stimulation and Suppression of DNA Synthesis in Lymphoid Cells," The Journal of Immunology, vol. 127, No. 5, Nov. 1981, Ikehara, et al.
"Extracellular ATP Increases Cytosolic Free Calcium in Thymocytes and Initiates the Blastogenesis of the Phorbol 12-Myristate 13-Acetate-Treated Medullary Population," Biochimica et Biophysica Acta, 927 (1987), 437-444, El-Moatassim, et al.
"Extracellular ATP Triggers Superoxide Production in Human Neutrophils," Biochemical and Biophysical Research Communications, vol. 162, No. 1, Jul. 14, 1989, Kuroki, et al.
"Experimental Cancer Therapy in Mice by Adenine Nucleotides," Eur. J. Cancer Clin. Oncol., vol. 24, No. 9, pp. 1491-1497, 1988, Rapaport.
"Anticancer Activities of Adenine Nucleotides in Mice are Mediated Through Expansion of Etythrocyte ATP Pools," Proc. Natl. Acad. Sci., vol. 86, pp. 1662-1666, Mar. 1989, Rapaport, et al.
"Extracellular ATP: Effects, Sources and Fate," Biochem. J. (1986) 233, 309-319, Gordon.
"Adenosine and Adenosine Triphosphate for Acute Blood Pressure Control," Seminars in Anesthesia, vol. VII, No. 3, Sep. 1988, 216-225, Flacke.
"State of Adenosine Phosphates During Dehydration of Yeast," Appl. Microbiol. Biotechnol., 1989, 31:194-199, Krallish, et al.
"The Formation of Adenosine in Rabbit Liver and Its Possible Role as a Direct Precursor of Erythrocyte Adenine Nucleotides," The Journal of Biological Chemistry, vol. 249, No. 3, Feb. 10, 1974, pp. 959-966, Lerner, et al.
"Incorporation of Adenosine Into ATP: Formation of Compartmentalized ATP," Proc. Natl. Acad. Sci., vol. 73, No. 9, 3122-3125, Sep. 1976, Rapaport et al.
"Complete Analysis of Cellular Nucleotides by Two-Dimensional Thin Layer Chromatography," The Journal of Biological Chemistry, vol. 257, No. 16, Aug. 1982, 9759-9769, Bochner, et al.
"Adenosine 5'-Triphosphate, Adenosine and Endothelium-Derived Relaxing Factor in Hypoxic Vasodilatation of the Heart," European Journal of Pharmacology, 165 (1989) 323-326, Hopwood, et al.
"Modulation of Platelet Function by Extracellular Adenosine Triphosphate," Blood, vol. 74, No. 3, Aug. 1989, 984-993, Soslau, et al.
"Body Composition Changes in Rats With Experimental Cancer Cachexia: Improvement With Exogenous Insulin," Cancer Research, 48, 2784-2787, May 1988, Moley, et al.
"Cachexia, the Metabolic Component of Neoplastic Diseases," Cancer Research, 37, 2327-2335, Jul. 1977, Costa.
"Cancer Cachexia and Gluconeogenesis," Ann. N.Y. Acad. Sci., 230, 103 (1974), Gold.
"Cachexia, Gluconeogenesis and Progressive Weight Loss in Cancer Patients," J. Theor. Biol., 1978, 73, 51-59, Stein.
"pppA2'p5'A2'p5'A: An Inhibitor of Protein Synthesis Synthesized With An Enzyme Fraction from Interferon-Treated Cells," Proc. Natl. Acad., vol. 75, No. 1, pp. 256-260, Jan. 1978, Kerr et al.
Elmaleh et al., ".sup.99m Tc-Labelled Nucleotides as Tumor-Seeking Radio Diagnostic Agents," Proc. Natl. Acad. Sci. USA, vol. 81, pp. 918-921 (Feb. 1984).
Chahwala et al., "Extracellular ATP Induces Ion Fluxes and Inhibits Growth of Friend Erythroleukemia Cells," Journal of Biological Chemistry, vol. 259, No. 22 (Nov. 25, 1984), pp. 13717-13722.
Biochemistry; Lehninger, Albert L.; pp. 300, 307 and 308; Worth Publishers, Inc., 1970.
Int. J. Tiss. Reac. V. XIII:(4) pp. 219-223 (1991).
Brown Johnnie R.
Wilson J. Oliver
LandOfFree
Utilization of adenine nucleotides and/or adenosine and inorgani does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Utilization of adenine nucleotides and/or adenosine and inorgani, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Utilization of adenine nucleotides and/or adenosine and inorgani will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2312153